We are live on ! Find out more
AZN icon

AstraZeneca
AZN

370 hedge funds and large institutions have $6.54B invested in AstraZeneca in 2015 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 124 increasing their positions, 133 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more call options, than puts

Call options by funds: $92.4M | Put options by funds: $66.4M

4% more capital invested

Capital invested by funds: $6.27B → $6.54B (+$274M)

0.33% more ownership

Funds ownership: 7.8% → 8.13% (+0.33%)

3% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 32

7% less repeat investments, than reductions

Existing positions increased: 124 | Existing positions reduced: 133

1% less funds holding

Funds holding: 375 → 370 (-5)

40% less funds holding in top 10

Funds holding in top 10: 5 → 3 (-2)

Holders
370
Holders Change
-5
Holders Change %
-1.33%
% of All Funds
10.33%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.08%
New
31
Increased
124
Reduced
133
Closed
32
Calls
$92.4M
Puts
$66.4M
Net Calls
+$26M
Net Calls Change
-$1.88M

Top Buyers

1
Bank of America
Bank of America
North Carolina
+$333M
2
Capital International Investors
Capital International Investors
California
+$109M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$54.5M
4
CI
Cambiar Investors
Colorado
+$46.6M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$44.3M

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$79.5M
2
BA
BlackRock Advisors
Delaware
-$37.7M
3
Norges Bank
Norges Bank
Norway
-$36M
4
Deutsche Bank
Deutsche Bank
Germany
-$18.5M
5
Ameriprise
Ameriprise
Minnesota
-$14.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$2.27B +$54.5M +828,835 +2%
Bank of America
2
Bank of America
North Carolina
$684M +$333M +5,060,103 +89%
Capital International Investors
3
Capital International Investors
California
$517M +$109M +1,659,400 +26%
EIP
4
Epoch Investment Partners
New York
$245M +$21M +318,702 +9%
CI
5
Cambiar Investors
Colorado
$179M +$46.6M +708,131 +34%
Renaissance Technologies
6
Renaissance Technologies
New York
$174M -$79.5M -1,208,150 -31%
BIM
7
BlackRock Investment Management
Delaware
$144M +$6.26M +95,148 +4%
PI
8
Putnam Investments
Massachusetts
$142M -$24.2K -368 -0%
SCCM
9
Schafer Cullen Capital Management
New York
$137M +$6.85M +104,115 +5%
Jennison Associates
10
Jennison Associates
New York
$124M +$40.2M +610,661 +45%
UBS Group
11
UBS Group
Switzerland
$101M -$2.33M -35,390 -2%
CCM
12
Camber Capital Management
Massachusetts
$79.5M – – –
Arrowstreet Capital
13
Arrowstreet Capital
Massachusetts
$73.7M +$44.3M +672,750 +139%
JP Morgan Chase
14
JP Morgan Chase
New York
$73.6M +$21M +318,880 +38%
Invesco
15
Invesco
Georgia
$72.9M -$1.31M -19,974 -2%
Fidelity Investments
16
Fidelity Investments
Massachusetts
$69.8M -$10.6M -161,628 -13%
Wells Fargo
17
Wells Fargo
California
$59.4M +$9.91M +150,570 +19%
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$57.9M -$201K -3,055 -0.3%
Northern Trust
19
Northern Trust
Illinois
$57M +$6.88M +104,627 +13%
CGT
20
Capital Guardian Trust
California
$56.8M +$11.3M +172,215 +24%
BA
21
BlackRock Advisors
Delaware
$51M -$37.7M -572,668 -42%
CCM
22
Cullen Capital Management
New York
$50.4M +$2.27M +34,550 +5%
Goldman Sachs
23
Goldman Sachs
New York
$50.3M +$19.1M +290,269 +58%
AAMU
24
Amundi Asset Management US
Massachusetts
$48.5M +$150K +2,279 +0.3%
Morgan Stanley
25
Morgan Stanley
New York
$43M +$1.45M +22,021 +3%
1
2 3 4 5

AZN Hedge Fund Activity: Q3 2015 in Review

370 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZN) for Q3 2015, worth a combined $6.54B — up 4.4% from $6.27B a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of AZN and 31 opened new positions — a net loss of 1 holder — while 133 trimmed existing stakes and 124 added.

The largest buyer was Bank of America, adding an estimated $333M. The largest seller was Renaissance Technologies, cutting an estimated $79.5M.

  • 370 institutional investors held AstraZeneca (AZN) as of Q3 2015, down from 375 in Q2 2015.
  • Funds reported $6.54B of AstraZeneca stock for Q3 2015, up 4.4% quarter-over-quarter.
  • 31 funds opened new AstraZeneca positions in Q3 2015 and 32 closed out, a net change of -1 holder.
  • The largest AstraZeneca buyer in Q3 2015 was Bank of America, an estimated $333M added.
  • The largest AstraZeneca seller in Q3 2015 was Renaissance Technologies, an estimated $79.5M sold.

Based on aggregated 13F filings for Q3 2015.